These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 35643554)

  • 21. The combination of supervised and unsupervised learning based risk stratification and phenotyping in pulmonary arterial hypertension-a long-term retrospective multicenter trial.
    Sonnweber T; Tymoszuk P; Steringer-Mascherbauer R; Sigmund E; Porod-Schneiderbauer S; Kohlbacher L; Theurl I; Lang I; Weiss G; Löffler-Ragg J
    BMC Pulm Med; 2023 Apr; 23(1):143. PubMed ID: 37098543
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characteristics, Long-term Survival, and Risk Assessment of Pediatric Pulmonary Arterial Hypertension in China: Insights From a National Multicenter Prospective Registry.
    Qian Y; Quan R; Chen X; Gu Q; Xiong C; Han H; Zhang G; Chen Y; Yu Z; Tian H; Liu Y; Zhu X; Li S; Zhang C; He J
    Chest; 2023 Jun; 163(6):1531-1542. PubMed ID: 36470418
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Discovery of Distinct Immune Phenotypes Using Machine Learning in Pulmonary Arterial Hypertension.
    Sweatt AJ; Hedlin HK; Balasubramanian V; Hsi A; Blum LK; Robinson WH; Haddad F; Hickey PM; Condliffe R; Lawrie A; Nicolls MR; Rabinovitch M; Khatri P; Zamanian RT
    Circ Res; 2019 Mar; 124(6):904-919. PubMed ID: 30661465
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Performance of screening algorithms in systemic sclerosis-related pulmonary arterial hypertension: a systematic review.
    Thakkar V; Stevens WM; Moore OA; Nikpour M
    Intern Med J; 2013 Jul; 43(7):751-60. PubMed ID: 23611651
    [TBL] [Abstract][Full Text] [Related]  

  • 25. International Validation of the SORG Machine-learning Algorithm for Predicting the Survival of Patients with Extremity Metastases Undergoing Surgical Treatment.
    Tseng TE; Lee CC; Yen HK; Groot OQ; Hou CH; Lin SY; Bongers MER; Hu MH; Karhade AV; Ko JC; Lai YH; Yang JJ; Verlaan JJ; Yang RS; Schwab JH; Lin WH
    Clin Orthop Relat Res; 2022 Feb; 480(2):367-378. PubMed ID: 34491920
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Combination of echocardiographic and pulmonary function test measures improves sensitivity for diagnosis of systemic sclerosis-associated pulmonary arterial hypertension: analysis of 2 cohorts.
    Gladue H; Steen V; Allanore Y; Saggar R; Saggar R; Maranian P; Berrocal VJ; Avouac J; Meune C; Trivedi M; Khanna D
    J Rheumatol; 2013 Oct; 40(10):1706-11. PubMed ID: 23950183
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of pulmonary arterial pressure in patients with connective tissue disease-associated pulmonary arterial hypertension by myocardial perfusion imaging.
    Wang Z; Li J; Wang X; Liu M; Liao M; Zhang C; Shang X
    Ann Noninvasive Electrocardiol; 2022 Mar; 27(2):e12927. PubMed ID: 34908208
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identifying individuals with physician-diagnosed chronic obstructive pulmonary disease in primary care electronic medical records: a retrospective chart abstraction study.
    Lee TM; Tu K; Wing LL; Gershon AS
    NPJ Prim Care Respir Med; 2017 May; 27(1):34. PubMed ID: 28507288
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Claims-Based Algorithms for Identifying Patients With Pulmonary Hypertension: A Comparison of Decision Rules and Machine-Learning Approaches.
    Ong MS; Klann JG; Lin KJ; Maron BA; Murphy SN; Natter MD; Mandl KD
    J Am Heart Assoc; 2020 Oct; 9(19):e016648. PubMed ID: 32990147
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A prognostic model for systemic lupus erythematosus-associated pulmonary arterial hypertension: CSTAR-PAH cohort study.
    Qu J; Li M; Zhang X; Zhang M; Zuo X; Zhu P; Ye S; Zhang W; Zheng Y; Qi W; Li Y; Zhang Z; Ding F; Gu J; Liu Y; Qian J; Huang C; Zhao J; Wang Q; Liu Y; Tian Z; Wang Y; Wei W; Zeng X
    Respir Res; 2023 Sep; 24(1):220. PubMed ID: 37689662
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evidence-based detection of pulmonary arterial hypertension in systemic sclerosis: the DETECT study.
    Coghlan JG; Denton CP; Grünig E; Bonderman D; Distler O; Khanna D; Müller-Ladner U; Pope JE; Vonk MC; Doelberg M; Chadha-Boreham H; Heinzl H; Rosenberg DM; McLaughlin VV; Seibold JR;
    Ann Rheum Dis; 2014 Jul; 73(7):1340-9. PubMed ID: 23687283
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Metabolic profiling of in vivo right ventricular function and exercise performance in pulmonary arterial hypertension.
    Simpson CE; Coursen J; Hsu S; Gough EK; Harlan R; Roux A; Aja S; Graham D; Kauffman M; Suresh K; Tedford RJ; Kolb TM; Mathai SC; Hassoun PM; Damico RL
    Am J Physiol Lung Cell Mol Physiol; 2023 Jun; 324(6):L836-L848. PubMed ID: 37070742
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Rare variant analysis of 4241 pulmonary arterial hypertension cases from an international consortium implicates FBLN2, PDGFD, and rare de novo variants in PAH.
    Zhu N; Swietlik EM; Welch CL; Pauciulo MW; Hagen JJ; Zhou X; Guo Y; Karten J; Pandya D; Tilly T; Lutz KA; Martin JM; Treacy CM; Rosenzweig EB; Krishnan U; Coleman AW; Gonzaga-Jauregui C; Lawrie A; Trembath RC; Wilkins MR; ; ; ; ; Morrell NW; Shen Y; Gräf S; Nichols WC; Chung WK
    Genome Med; 2021 May; 13(1):80. PubMed ID: 33971972
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In systemic sclerosis, the TAPSE/sPAP ratio can be used in addition to the DETECT algorithm for pulmonary arterial hypertension diagnosis.
    Colalillo A; Grimaldi MC; Vaiarello V; Pellicano C; Leodori G; Gigante A; Romaniello A; Rosato E
    Rheumatology (Oxford); 2022 May; 61(6):2450-2456. PubMed ID: 34605890
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Analysis of m
    Wang D; Mo Y; Zhang D; Bai Y
    Front Immunol; 2022; 13():1014509. PubMed ID: 36544768
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Development of algorithms to identify individuals with Neurofibromatosis type 1 within administrative data and electronic medical records in Ontario, Canada.
    Barnett C; Candido E; Chen B; Pequeno P; Parkin PC; Tu K
    Orphanet J Rare Dis; 2022 Aug; 17(1):321. PubMed ID: 36028856
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognostic Value of Early Risk Stratification in Pediatric Pulmonary Arterial Hypertension.
    Ablonczy L; Ferenci T; Somoskövi O; Osváth R; Reusz GS; Kis E
    Transplant Proc; 2021 Jun; 53(5):1439-1442. PubMed ID: 33622612
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Guideline implementation and early risk assessment in pulmonary arterial hypertension associated with congenital heart disease: A retrospective cohort study.
    Deng X; Jin B; Li S; Li Y; Zhou H; Wu Y; Yan M; Hu Y; Qiu Q; Zhang G; Zheng X
    Clin Respir J; 2019 Nov; 13(11):693-699. PubMed ID: 31419027
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Classification, diagnosis and treatment status of pulmonary hypertension from 2012 to 2019: a single center study in Yunnan province].
    Feng XL; Lu YB; Yang D; Xue Q; Zhang JL; Lin CR; Gan P; Zhang WH; Guang XF; Dai HL
    Zhonghua Xin Xue Guan Bing Za Zhi; 2023 Nov; 51(11):1188-1193. PubMed ID: 37963755
    [No Abstract]   [Full Text] [Related]  

  • 40. Predictors of the response to phosphodiesterase-5 inhibitors in pulmonary arterial hypertension: an analysis of the Spanish registry.
    Garcia AR; Blanco I; Ramon L; Pérez-Sagredo J; Guerra-Ramos FJ; Martín-Ontiyuelo C; Tura-Ceide O; Pastor-Pérez F; Escribano-Subías P; Barberà JA
    Respir Res; 2023 Sep; 24(1):223. PubMed ID: 37715261
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.